FTC General Counsel Lucas Croslow filed an ... pharmacies and wrongly inflated costs for specialty generic drugs. CVS Caremark, Express Scripts and OptumRx, which have said the reports are ...

The FTC on Tuesday paused its in-house case against CVS Health’s CVS Caremark, Cigna’s Express Scripts and UnitedHealth Group’s OptumRx, which alleges the companies wrongly inflated insulin ...

Driving the news: The FTC issued the stay in the case against CVS Caremark, OptumRx and Express Scripts in response to a motion "citing the fact that there are currently no sitting Commissioners ...

CVS Caremark, and Express Scripts. The lawsuit could be filed within weeks – potentially before the end of the month – and could end up being a signature action by FTC chair Lina Khan ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

The Federal Trade Commission is pausing ... administration accuses Caremark, Express Scripts and Optum Rx — the so-called “Big Three” PBMs that are owned by CVS, Cigna and UnitedHealth ...

The law in particular will affect CVS and UnitedHealth, both of which operate physical pharmacies in the state along with ...

CVS Caremark added five new companies to its Point Solution Management Service, which it launched last year to make it easier for businesses to implement digital health tools. CVS Caremark CMO ...

Also Read: FTC Pauses Lawsuit Against CVS ... responsible for the operational performance across CVS Caremark, CVS Pharmacy, and the company's Healthcare Delivery businesses. In addition, the company ...

Arkansas is leading the charge in regulating PBMs, which the Federal Trade Commission said in a 2024 ... the practices of healthcare companies like CVS, which owns their own insurance company ...